AFAP1L2 and breast cancer: Specifically, Xie and colleagues demonstrated that knockdown of XB130, a cytosolic signal transduction protein found upregulated in breast cancers and associated with poor prognosis, disrupts EMT and Wnt signaling, culminating in decreased CSC activity and tumor-initiating capacity in breast cancer cells (Xie et al., 2019).